IMMUNOMEDICS, INC. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d36cd3bb-be2a-466d-845e-a5792159f46a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-324.8M | 2019-01-01 – 2019-12-31 | evidence 0000722830-20-000003 |
| FY 2018 | $-141.0M | 2017-07-01 – 2018-06-30 | evidence 0000722830-19-000005 |
| FY 2017 | $-79.2M | 2016-07-01 – 2017-06-30 | evidence 0000722830-19-000005 |
| FY 2016 | $-59.0M | 2015-07-01 – 2016-06-30 | evidence 0000722830-19-000005 |
| FY 2015 | $-46.2M | 2014-07-01 – 2015-06-30 | evidence 0001193125-15-296226 |
| FY 2014 | $-35.6M | 2013-07-01 – 2014-06-30 | evidence 0001193125-14-320153 |
| FY 2013 | $-30.8M | 2012-07-01 – 2013-06-30 | evidence 0001193125-14-104801 |
| FY 2012 | $1.4M | 2011-07-01 – 2012-06-30 | evidence 0001193125-14-104801 |
| FY 2011 | $-18.2M | 2010-07-01 – 2011-06-30 | evidence 0001193125-14-104801 |
| FY 2010 | $33.9M | 2009-07-01 – 2010-06-30 | evidence 0001193125-12-366797 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).